Plato Investment Management LTD Bristol Myers Squibb CO Transaction History
Plato Investment Management LTD
- $1.36 Trillion
- Q4 2024
A detailed history of Plato Investment Management LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Plato Investment Management LTD holds 122,224 shares of BMY stock, worth $7.02 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
122,224
Previous 117,401
4.11%
Holding current value
$7.02 Million
Previous $6.07 Billion
14.34%
% of portfolio
0.51%
Previous 0.49%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,632Shares Held
1.47BCall Options Held
31.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA189MShares$10.8 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.11 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.33 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.47 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.46 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $122B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...